MET and cancer: The potential positive loop involving MET, NMDAR2B, and mTOR signaling, as well as the implications of these interactions in promoting pro-migratory functions, introduces a novel dimension to our understanding of cancer progression, paving the way for future research to explore the therapeutic possibilities arising from targeting these signaling pathways in cancer.